{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:12:48Z","timestamp":1791832368390,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2012R1A3A2026454"],"award-info":[{"award-number":["2012R1A3A2026454"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015M3A9B6029138"],"award-info":[{"award-number":["2015M3A9B6029138"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1C1B6005004"],"award-info":[{"award-number":["2018R1C1B6005004"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003715","name":"Korea Research Institute of Bioscience and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Abdominal aortic aneurysm (AAA) is an inflammatory vascular disease characterized by structural deterioration of the aorta caused by inflammation and oxidative stress, leading to aortic dilatation and rupture. Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, has been reported as a potential negative regulator of inflammatory vascular diseases, and it has been identified as a protein that is increased in patients with ruptured AAA compared to patients with nonruptured AAA. In this study, we demonstrated that PRDX2 was a pivotal factor involved in the inhibition of AAA progression. PRDX2 levels were increased in AAA compared with those in normal aortas in both humans and mice. Ultrasound imaging revealed that the loss of PRDX2 accelerated the development of AAA in the early stages and increased AAA incidence in mice infused with angiotensin II (Ang II). <jats:italic>Prdx2<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> mice infused with Ang II exhibited increased aortic dilatation and maximal aortic diameter without a change in blood pressure. Structural deterioration of the aortas from <jats:italic>Prdx2<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> mice infused with Ang II was associated with increases in the degradation of elastin, oxidative stress, and intramural thrombi caused by microhemorrhages, immature neovessels, and the activation of matrix metalloproteinases compared to that observed in controls. Moreover, an increase in inflammatory responses, including the production of cell adhesion molecules and the accumulation of inflammatory cells and proinflammatory cytokines due to PRDX2 deficiency, accelerated Ang II-induced AAA progression. Our data confirm that PRDX2 plays a role as a negative regulator of the pathological process of AAA and suggest that increasing PRDX2 activity may be a novel strategy for the prevention and treatment of AAA.<\/jats:p>","DOI":"10.1038\/s12276-020-00498-3","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T07:02:49Z","timestamp":1600066969000},"page":"1587-1601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Deficiency of peroxiredoxin 2 exacerbates angiotensin II-induced abdominal aortic aneurysm"],"prefix":"10.1038","volume":"52","author":[{"given":"Se-Jin","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ji","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Young","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinai","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Hyuk","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hak","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6489-9949","authenticated-orcid":false,"given":"Jong-Gil","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goo Taeg","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"498_CR1","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMcp1401430","volume":"371","author":"KC Kent","year":"2014","unstructured":"Kent, K. C. Clinical practice. Abdominal aortic aneurysms. New Engl. J. Med. 371, 2101\u20132108 (2014).","journal-title":"New Engl. J. Med."},{"key":"498_CR2","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"EJ Benjamin","year":"2018","unstructured":"Benjamin, E. J. et al. Heart Disease and Stroke Statistics-2018 update: a report from the American Heart Association. Circulation 137, e67\u2013e492 (2018).","journal-title":"Circulation"},{"key":"498_CR3","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(05)66459-8","volume":"365","author":"N Sakalihasan","year":"2005","unstructured":"Sakalihasan, N., Limet, R. & Defawe, O. D. Abdominal aortic aneurysm. Lancet 365, 1577\u20131589 (2005).","journal-title":"Lancet"},{"key":"498_CR4","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/01.ATV.15.8.1145","volume":"15","author":"T Freestone","year":"1995","unstructured":"Freestone, T. et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 15, 1145\u20131151 (1995).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"498_CR5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0741-5214(03)00148-4","volume":"38","author":"J Zhang","year":"2003","unstructured":"Zhang, J. et al. Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury. J. Vasc. Surg. 38, 360\u2013367 (2003).","journal-title":"J. Vasc. Surg."},{"key":"498_CR6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1749-6632.1996.tb33331.x","volume":"800","author":"D Paik","year":"1996","unstructured":"Paik, D. & Tilson, M. D. Neovascularization in the abdominal aortic aneurysm. Endothelial nitric oxide synthase, nitric oxide, and elastolysis. Ann. N. Y. Acad. Sci. 800, 277 (1996).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"498_CR7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.ATV.0000013778.72404.30","volume":"22","author":"FJ Miller Jr.","year":"2002","unstructured":"Miller, F. J. Jr. et al. Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling. Arterioscler. Thromb. Vasc. Biol. 22, 560\u2013565 (2002).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"498_CR8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/CIRCULATIONAHA.105.607168","volume":"114","author":"M Thomas","year":"2006","unstructured":"Thomas, M. et al. Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation 114, 404\u2013413 (2006).","journal-title":"Circulation"},{"key":"498_CR9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/HYPERTENSIONAHA.107.089706","volume":"50","author":"G Gavazzi","year":"2007","unstructured":"Gavazzi, G. et al. NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension 50, 189\u2013196 (2007).","journal-title":"Hypertension"},{"key":"498_CR10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cpcardiol.2010.08.004","volume":"35","author":"JV Moxon","year":"2010","unstructured":"Moxon, J. V. et al. Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects. Curr. Probl. Cardiol. 35, 512\u2013548 (2010).","journal-title":"Curr. Probl. Cardiol."},{"key":"498_CR11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0741-5214(02)00129-5","volume":"36","author":"AB Wilmink","year":"2002","unstructured":"Wilmink, A. B. et al. Are antihypertensive drugs associated with abdominal aortic aneurysms? J. Vasc. Surg. 36, 751\u2013757 (2002).","journal-title":"J. Vasc. Surg."},{"key":"498_CR12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1067\/mva.2002.121308","volume":"35","author":"Propanolol Aneurysm Trial Investigators.","year":"2002","unstructured":"Propanolol Aneurysm Trial Investigators. Propranolol for small abdominal aortic aneurysms: results of a randomized trial. J. Vasc. Surg. 35, 72\u201379 (2002).","journal-title":"J. Vasc. Surg."},{"key":"498_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvs.2010.02.264","volume":"52","author":"MJ Sweeting","year":"2010","unstructured":"Sweeting, M. J., Thompson, S. G., Brown, L. C., Greenhalgh, R. M. & Powell, J. T. Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms. J. Vasc. Surg. 52, 1\u20134 (2010).","journal-title":"J. Vasc. Surg."},{"key":"498_CR14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.avsg.2011.09.003","volume":"26","author":"ST Mastoraki","year":"2012","unstructured":"Mastoraki, S. T. et al. Treatment with simvastatin inhibits the formation of abdominal aortic aneurysms in rabbits. Ann. Vasc. Surg. 26, 250\u2013258 (2012).","journal-title":"Ann. Vasc. Surg."},{"key":"498_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1024\/0301-1526\/a000161","volume":"41","author":"D Periard","year":"2012","unstructured":"Periard, D. et al. Reduction of small infrarenal abdominal aortic aneurysm expansion rate by statins. Vasa. Z. fur Gefasskrankheiten 41, 35\u201342 (2012).","journal-title":"Vasa. Z. fur Gefasskrankheiten"},{"key":"498_CR16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejvs.2012.06.021","volume":"44","author":"H Takagi","year":"2012","unstructured":"Takagi, H. et al. Effects of statin therapy on abdominal aortic aneurysm growth: a meta-analysis and meta-regression of observational comparative studies. Eur. J. Vasc. Endovasc. Surg. 44, 287\u2013292 (2012).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"498_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mva.2002.125018","volume":"36","author":"BT Baxter","year":"2002","unstructured":"Baxter, B. T. et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J. Vasc. Surg. 36, 1\u201312 (2002).","journal-title":"J. Vasc. Surg."},{"key":"498_CR18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0741-5214(98)70035-7","volume":"28","author":"JA Curci","year":"1998","unstructured":"Curci, J. A., Petrinec, D., Liao, S., Golub, L. M. & Thompson, R. W. Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines. J. Vasc. Surg. 28, 1082\u20131093 (1998).","journal-title":"J. Vasc. Surg."},{"key":"498_CR19","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.freeradbiomed.2005.02.026","volume":"38","author":"SG Rhee","year":"2005","unstructured":"Rhee, S. G., Chae, H. Z. & Kim, K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38, 1543\u20131552 (2005).","journal-title":"Free Radic. Biol. Med."},{"key":"498_CR20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ceb.2005.02.004","volume":"17","author":"SG Rhee","year":"2005","unstructured":"Rhee, S. G. et al. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell Biol. 17, 183\u2013189 (2005).","journal-title":"Curr. Opin. Cell Biol."},{"key":"498_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14348\/molcells.2016.2368","volume":"39","author":"SG Rhee","year":"2016","unstructured":"Rhee, S. G. Overview on peroxiredoxin. Mol. Cells 39, 1\u20135 (2016).","journal-title":"Mol. Cells"},{"key":"498_CR22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0968-0004(02)00003-8","volume":"28","author":"ZA Wood","year":"2003","unstructured":"Wood, Z. A., Schroder, E., Robin Harris, J. & Poole, L. B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28, 32\u201340 (2003).","journal-title":"Trends Biochem. Sci."},{"key":"498_CR23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-8227(99)00037-6","volume":"45","author":"HZ Chae","year":"1999","unstructured":"Chae, H. Z., Kim, H. J., Kang, S. W. & Rhee, S. G. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res. Clin. Pract. 45, 101\u2013112 (1999).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"498_CR24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/15548627.2017.1327942","volume":"14","author":"SJ Jeong","year":"2018","unstructured":"Jeong, S. J. et al. Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux. Autophagy 14, 120\u2013133 (2018).","journal-title":"Autophagy"},{"key":"498_CR25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCRESAHA.111.245530","volume":"109","author":"JG Park","year":"2011","unstructured":"Park, J. G. et al. Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice. Circulation Res. 109, 739\u2013749 (2011).","journal-title":"Circulation Res."},{"key":"498_CR26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature03587","volume":"435","author":"MH Choi","year":"2005","unstructured":"Choi, M. H. et al. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435, 347\u2013353 (2005).","journal-title":"Nature"},{"key":"498_CR27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jvs.2008.08.097","volume":"49","author":"S Urbonavicius","year":"2009","unstructured":"Urbonavicius, S. et al. Proteomic identification of differentially expressed proteins in aortic wall of patients with ruptured and nonruptured abdominal aortic aneurysms. J. Vasc. Surg. 49, 455\u2013463 (2009).","journal-title":"J. Vasc. Surg."},{"key":"498_CR28","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjp.0704331","volume":"134","author":"A Daugherty","year":"2001","unstructured":"Daugherty, A., Manning, M. W. & Cassis, L. A. Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br. J. Pharmacol. 134, 865\u2013870 (2001).","journal-title":"Br. J. Pharmacol."},{"key":"498_CR29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1023\/A:1016357510143","volume":"23","author":"JL Ray","year":"2001","unstructured":"Ray, J. L., Leach, R., Herbert, J. M. & Benson, M. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci. 23, 185\u2013188 (2001).","journal-title":"Methods Cell Sci."},{"key":"498_CR30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1472-8206.2005.00371.x","volume":"19","author":"F Valentin","year":"2005","unstructured":"Valentin, F., Bueb, J. L., Kieffer, P., Tschirhart, E. & Atkinson, J. Oxidative stress activates MMP-2 in cultured human coronary smooth muscle cells. Fundam. Clin. Pharm. 19, 661\u2013667 (2005).","journal-title":"Fundam. Clin. Pharm."},{"key":"498_CR31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cardiores.2006.02.033","volume":"71","author":"RE Clempus","year":"2006","unstructured":"Clempus, R. E. & Griendling, K. K. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovascular Res. 71, 216\u2013225 (2006).","journal-title":"Cardiovascular Res."},{"key":"498_CR32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.ATV.0000257552.94483.14","volume":"27","author":"ML McCormick","year":"2007","unstructured":"McCormick, M. L., Gavrila, D. & Weintraub, N. L. Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 27, 461\u2013469 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"498_CR33","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bbadis.2015.01.015","volume":"1852","author":"M Csala","year":"2015","unstructured":"Csala, M. et al. On the role of 4-hydroxynonenal in health and disease. Biochimica et. biophysica acta 1852, 826\u2013838 (2015).","journal-title":"Biochimica et. biophysica acta"},{"key":"498_CR34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuroscience.2018.12.008","volume":"399","author":"CE Millett","year":"2019","unstructured":"Millett, C. E., Phillips, B. E. & Saunders, E. F. H. The Sex-specific Effects of LPS on Depressive-like Behavior and Oxidative Stress in the Hippocampus of the Mouse. Neuroscience 399, 77\u201388 (2019).","journal-title":"Neuroscience"},{"key":"498_CR35","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.bbabio.2016.03.012","volume":"1857","author":"L Tretter","year":"2016","unstructured":"Tretter, L., Patocs, A. & Chinopoulos, C. Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis. Biochimica et. biophysica acta 1857, 1086\u20131101 (2016).","journal-title":"Biochimica et. biophysica acta"},{"key":"498_CR36","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1182\/blood-2002-08-2548","volume":"101","author":"TH Lee","year":"2003","unstructured":"Lee, T. H. et al. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 101, 5033\u20135038 (2003).","journal-title":"Blood"},{"key":"498_CR37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2119\/molmed.2015.00033","volume":"21","author":"L Mullen","year":"2015","unstructured":"Mullen, L., Hanschmann, E. M., Lillig, C. H., Herzenberg, L. A. & Ghezzi, P. Cysteine Oxidation Targets Peroxiredoxins 1 and 2 for Exosomal Release through a Novel Mechanism of Redox-Dependent Secretion. Mol. Med 21, 98\u2013108 (2015).","journal-title":"Mol. Med"},{"key":"498_CR38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/ATVBAHA.110.214429","volume":"31","author":"R Martinez-Pinna","year":"2011","unstructured":"Martinez-Pinna, R. et al. Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 31, 935\u2013943 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"498_CR39","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0008-6363(03)00523-6","volume":"59","author":"J Ejiri","year":"2003","unstructured":"Ejiri, J. et al. Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker. Cardiovasc. Res. 59, 988\u2013996 (2003).","journal-title":"Cardiovasc. Res."},{"key":"498_CR40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-5793(97)00093-8","volume":"404","author":"PF Li","year":"1997","unstructured":"Li, P. F., Dietz, R. & von Harsdorf, R. Reactive oxygen species induce apoptosis of vascular smooth muscle cell. FEBS Lett. 404, 249\u2013252 (1997).","journal-title":"FEBS Lett."},{"key":"498_CR41","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1083\/jcb.141.6.1423","volume":"141","author":"S Tan","year":"1998","unstructured":"Tan, S., Sagara, Y., Liu, Y., Maher, P. & Schubert, D. The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141, 1423\u20131432 (1998).","journal-title":"J. Cell Biol."},{"key":"498_CR42","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/374644","volume":"187","author":"DN Meli","year":"2003","unstructured":"Meli, D. N., Christen, S. & Leib, S. L. Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway. J. Infect. Dis. 187, 1411\u20131415 (2003).","journal-title":"J. Infect. Dis."},{"key":"498_CR43","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1172\/JCI119076","volume":"98","author":"S Rajagopalan","year":"1996","unstructured":"Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G. & Galis, Z. S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Investig. 98, 2572\u20132579 (1996).","journal-title":"J. Clin. Investig."},{"key":"498_CR44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1172\/JCI0215334","volume":"110","author":"GM Longo","year":"2002","unstructured":"Longo, G. M. et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Investig. 110, 625\u2013632 (2002).","journal-title":"J. Clin. Investig."},{"key":"498_CR45","first-page":"II224","volume":"90","author":"KM Newman","year":"1994","unstructured":"Newman, K. M., Jean-Claude, J., Li, H., Ramey, W. G. & Tilson, M. D. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 90, II224\u2013II227 (1994).","journal-title":"Circulation"},{"key":"498_CR46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.CIR.99.1.96","volume":"99","author":"EL Henderson","year":"1999","unstructured":"Henderson, E. L. et al. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 99, 96\u2013104 (1999).","journal-title":"Circulation"},{"key":"498_CR47","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.270.5234.296","volume":"270","author":"M Sundaresan","year":"1995","unstructured":"Sundaresan, M., Yu, Z. X., Ferrans, V. J., Irani, K. & Finkel, T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270, 296\u2013299 (1995).","journal-title":"Science"},{"key":"498_CR48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1445-2197.1996.tb01192.x","volume":"66","author":"MI Patel","year":"1996","unstructured":"Patel, M. I., Ghosh, P., Melrose, J. & Appleberg, M. Smooth muscle cell migration and proliferation is enhanced in abdominal aortic aneurysms. Aust. N. Z. J. Surg. 66, 305\u2013308 (1996).","journal-title":"Aust. N. Z. J. Surg."},{"key":"498_CR49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.molcel.2011.08.040","volume":"44","author":"DH Kang","year":"2011","unstructured":"Kang, D. H. et al. Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. Mol. Cell 44, 545\u2013558 (2011).","journal-title":"Mol. Cell"},{"key":"498_CR50","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/1570161043385556","volume":"2","author":"E Escobar","year":"2004","unstructured":"Escobar, E., Rodriguez-Reyna, T. S., Arrieta, O. & Sotelo, J. Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer. Curr. Vasc. Pharmacol. 2, 385\u2013399 (2004).","journal-title":"Curr. Vasc. Pharmacol."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00498-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00498-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00498-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T23:05:55Z","timestamp":1631574355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00498-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["498"],"URL":"https:\/\/doi.org\/10.1038\/s12276-020-00498-3","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"26 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}